Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters

Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters

Andes virus, an orthohantavirus endemic to South America, causes severe hantavirus cardiopulmonary syndrome associated with human-to-human transmission. No approved treatments or vaccines against this virus are available. We show that a combined treatment with 2 monoclonal antibodies protected Syri...

Full description

Bibliographic Details
Main Authors: Brandi N. Williamson, Joseph Prescott, Jose L. Garrido, Raymond A. Alvarez, Heinz Feldmann, Maria I. Barría
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-10-01
Series:Emerging Infectious Diseases
Subjects:
recombinant human monoclonal antibodies
Andes orthohantavirus
Syrian hamster
viruses
zoonoses
Online Access:https://wwwnc.cdc.gov/eid/article/27/10/21-0735_article

Internet

https://wwwnc.cdc.gov/eid/article/27/10/21-0735_article

Similar Items